CGTX Cognition Therapeutics, Inc. - Common Stock

NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗
$1.00
Price · Aug 18, 2026
Fundamentals as of Aug 7, 2026

CGTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.00
Market Cap
$89M
P/E (TTM)
-3.1
EPS (TTM)
$-0.32
Revenue (TTM)
Div Yield
ROE
-113.7%
Debt/Equity
52W Range
$1 – $4

CGTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-0.32
6-point trend, +98.7%
2020-12-31 2025-12-31
Free Cash Flow
4-point trend, -678.5%
2021-12-31 2024-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CGTX
Peer Median
P/E (TTM)
5-point trend, -108.9%
-3.1
44.2
P/S (TTM)
5-point trend, -2624.5%
-3178.3
15.5
P/B
5-point trend, +27.8%
2.6
3.3

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CGTX
Peer Median
ROA
5-point trend, -68.9%
-59.8%
-62.1%
ROE
5-point trend, -272.0%
-113.7%
-79.9%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CGTX
Peer Median
Current Ratio
5-point trend, -54.1%
3.4
3.4
Quick Ratio
5-point trend, -62.0%
2.6

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CGTX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CGTX
Peer Median
EPS (Diluted)
5-point trend, +89.8%
$-0.32

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CGTX
Peer Median

CGTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 9 analysts
  • Strong Buy 2 22.2%
  • Buy 6 66.7%
  • Hold 1 11.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-15
Median target $3.00 +199.7%
Mean target $3.33 +233.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.01%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.04 $-0.06 0.02%
March 31, 2026 $-0.05 $-0.07 0.02%
Dec. 31, 2025 $-0.05 $-0.09 0.04%
Sept. 30, 2025 $-0.06 $-0.10 0.04%
June 30, 2025 $-0.11 $-0.11 -0.00%
March 31, 2025 $-0.14 $-0.11 -0.03%
Dec. 31, 2024 $-0.17 $-0.14 -0.03%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CGTX $120M -4.2 -113.7%
PLYX -193.7%
RANI -3.0 58.9% -1817.1% -169.6%
RFL -1.6 44.0% -3328.2% -34.6%
VRCA $143M -4.9 370.2% -50.3% -492.8%
LONA $71M -0.3 -353.4%
CING
ELOX 30.1%
TELO $46M -4.0 -325.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 12
Annual Income Statement data for CGTX
Metric Trend 202520242023202220212020
R&D Expense 6-point trend, +188.6% $37M $42M $37M $30M $19M $13M
SG&A Expense 6-point trend, +134.8% $11M $12M $14M $13M $10M $5M
Operating Expenses 6-point trend, +174.6% $48M $54M $51M $44M $29M $17M
Operating Income 6-point trend, -174.6% $-48M $-54M $-51M $-44M $-29M $-17M
Other Non-op 6-point trend, +154.1% $24M $20M $25M $22M $17M $10M
Income Tax Flat — no change across 5 periods $0 $0 $0 $0 $0 ·
Net Income 6-point trend, -199.6% $-23M $-34M $-26M $-21M $-12M $-8M
EPS (Basic) 6-point trend, +98.7% $-0.32 $-0.86 $-0.86 $-0.91 $-3.13 $-23.76
EPS (Diluted) 6-point trend, +98.7% $-0.32 $-0.86 $-0.86 $-0.91 $-3.13 $-23.76
Shares (Basic) 6-point trend, +14221.1% 72,766,983 39,730,148 30,029,087 23,640,199 5,190,883 508,112
Shares (Diluted) 6-point trend, +14221.1% 72,766,983 39,730,148 30,029,087 23,640,199 5,190,883 508,112
EBITDA 5-point trend, -67.6% $-48M $-54M $-51M $-43M $-29M ·
Balance Sheet 22
Annual Balance Sheet data for CGTX
Metric Trend 202520242023202220212020
Cash & Equivalents 6-point trend, +609.4% $37M $25M $30M $42M $55M $5M
Prepaid Expense 6-point trend, +96.3% $1M $2M $3M $2M $2M $544.0K
Other Current Assets 2-point trend, -52.2% · · · · $11.0K $23.0K
Current Assets 6-point trend, +594.7% $48M $30M $34M $48M $59M $7M
PP&E (Net) 6-point trend, -55.9% $93.0K $181.0K $284.0K $233.0K $145.0K $211.0K
PP&E (Gross) 6-point trend, -71.7% $280.0K $1M $1M $1M $1M $988.0K
Accum. Depreciation 6-point trend, -75.9% $187.0K $1M $1M $953.0K $870.0K $777.0K
Total Assets 6-point trend, +579.7% $48M $30M $35M $50M $59M $7M
Accounts Payable 6-point trend, -44.1% $1M $2M $4M $3M $4M $2M
Accrued Liabilities 6-point trend, +1106.7% $12M $8M $4M $2M $2M $994.0K
Current Liabilities 6-point trend, +328.4% $14M $11M $10M $8M $8M $3M
Capital Leases 4-point trend, -71.9% $195.0K $342.0K $520.0K $695.0K · ·
Deferred Tax 6-point trend, +204.5% $67.0K $110.0K $147.0K $178.0K $13.0K $22.0K
Other Non-current Liabilities 3-point trend, +0.00 · · $0 $2M $0 ·
Total Liabilities 6-point trend, -29.2% $14M $11M $11M $10M $8M $20M
Common Stock 6-point trend, +8900.0% $90.0K $60.0K $32.0K $29.0K $22.0K $1.0K
Paid-in Capital 6-point trend, +104777.5% $233M $194M $166M $156M $145M $222.0K
Retained Earnings 6-point trend, -191.2% $-199M $-175M $-141M $-115M $-94M $-68M
AOCI 4-point trend, -4.3% · · $-195.0K $-199.0K $-198.0K $-187.0K
Stockholders' Equity 6-point trend, +150.3% $34M $19M $24M $40M $51M $-68M
Liabilities + Equity 6-point trend, +579.7% $48M $30M $35M $50M $59M $7M
Shares Outstanding 6-point trend, +16400.6% 88,904,161 59,854,877 32,165,478 28,991,548 22,230,032 538,793
Cash Flow 10
Annual Cash Flow data for CGTX
Metric Trend 202520242023202220212020
D&A 6-point trend, -63.3% $36.0K $107.0K $96.0K $83.0K $93.0K $98.0K
Stock-based Comp 6-point trend, +339.4% $2M $4M $4M $4M $5M $475.0K
Deferred Tax Flat — no change across 3 periods · $0 $0 $0 · ·
Other Non-cash 5-point trend, -214.8% $-3M $2M $5M $-791.0K $3M ·
Operating Cash Flow 6-point trend, -616.2% $-25M $-28M $-16M $-19M $-4M $-3M
CapEx 5-point trend, -60.0% · $4.0K $147.0K $171.0K $27.0K $10.0K
Investing Cash Flow 6-point trend, +190.0% $9.0K $-4.0K $-147.0K $-171.0K $-27.0K $-10.0K
Financing Cash Flow 6-point trend, +534.3% $37M $24M $5M $6M $53M $6M
Net Change in Cash 6-point trend, +421.6% $12M $-5M $-12M $-13M $50M $2M
Free Cash Flow 4-point trend, -678.5% · $-28M $-16M $-19M $-4M ·
Profitability 5
Annual Profitability data for CGTX
Metric Trend 202520242023202220212020
Operating Margin 3-point trend, +5766.3% · · 187866.7% 155539.3% 3202.5% ·
Net Margin 3-point trend, +7179.9% · · 95511.1% 76417.9% 1312.0% ·
EBITDA Margin 3-point trend, +5774.3% · · 187511.1% 155242.9% 3192.1% ·
ROA 5-point trend, -68.9% -59.8% -103.9% -60.3% -39.1% -35.4% ·
ROE 5-point trend, -272.0% -113.7% -204.5% -96.6% -53.8% 66.1% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for CGTX
Metric Trend 202520242023202220212020
Current Ratio 5-point trend, -54.1% 3.4 2.7 3.4 6.1 7.5 ·
Quick Ratio 5-point trend, -62.0% 2.6 2.2 2.9 5.3 7.0 ·
Efficiency 1
Annual Efficiency data for CGTX
Metric Trend 202520242023202220212020
Asset Turnover 3-point trend, +97.8% · · -0.0 -0.0 -0.0 ·
Per Share 5
Annual Per Share data for CGTX
Metric Trend 202520242023202220212020
Book Value / Share 5-point trend, -83.3% $0.39 $0.31 $0.76 $1.39 $2.31 ·
Revenue / Share 3-point trend, +99.5% · · $-0.00 $-0.00 $-0.17 ·
Cash Flow / Share 5-point trend, +51.7% $-0.34 $-0.72 $-0.53 $-0.78 $-0.70 ·
Cash / Share 5-point trend, -83.2% $0.41 $0.42 $0.93 $1.43 $2.46 ·
EPS (TTM) 5-point trend, +89.8% $-0.32 $-0.86 $-0.86 $-0.91 $-3.13 ·
Valuation (TTM) 10
Annual Valuation (TTM) data for CGTX
Metric Trend 202520242023202220212020
Revenue TTM 5-point trend, +96.9% $-28.0K $-28.0K $-27.0K $-28.0K $-893.0K ·
Net Income TTM 5-point trend, -100.5% $-23M $-34M $-26M $-21M $-12M ·
Market Cap 5-point trend, -14.6% $120M $42M $60M $61M $140M ·
P/E 5-point trend, -108.9% -4.2 -0.8 -2.2 -2.3 -2.0 ·
P/S 5-point trend, -2624.5% -4286.5 -1498.5 -2203.9 -2174.4 -157.3 ·
P/B 5-point trend, +27.8% 3.5 2.2 2.4 1.5 2.7 ·
P / Tangible Book 5-point trend, +27.8% 3.5 2.2 2.4 1.5 2.7 ·
P / Cash Flow 5-point trend, +87.4% -4.9 -1.5 -3.7 -3.3 -38.7 ·
P / FCF 4-point trend, +96.2% · -1.5 -3.7 -3.3 -38.4 ·
Earnings Yield 5-point trend, +52.2% -23.7% -122.7% -46.5% -43.3% -49.5% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Operating Margin % 187866.7%155539.3%3202.5%
Net Income $-23M$-34M$-26M$-21M$-12M
Diluted EPS $-0.32$-0.86$-0.86$-0.91$-3.13
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 3.42.73.46.17.5
Quick Ratio 2.62.22.95.37.0
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-28M$-16M$-19M$-4M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 70 filers · $24.3M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
6 (-5 vs prior Q) 13 (+1 vs prior Q) 20 (+3 vs prior Q) 10 (-2 vs prior Q) +4.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BIOS Capital Management, LP $6,324,891 5,499,905 26.03% Shares
DAVENPORT & Co LLC $4,898,438 4,259,511 20.16% Shares
VANGUARD CAPITAL MANAGEMENT LLC $3,954,591 3,438,775 16.27% Shares
Chescapmanager LLC $1,146,583 997,029 4.72% Shares
GEODE CAPITAL MANAGEMENT, LLC $845,023 734,329 3.48% Shares
RENAISSANCE TECHNOLOGIES LLC $797,281 693,288 3.28% Shares
Hilton Capital Management, LLC $631,293 548,950 2.60% Shares
VANGUARD GROUP INC $625,973 463,684 2.58% Shares
VANGUARD FIDUCIARY TRUST CO $584,453 508,220 2.41% Shares
CM Management, LLC $517,500 450,000 2.13% Shares
Dauntless Investment Group, LLC $427,456 371,701 1.76% Shares
Sigma Planning Corp $416,605 362,265 1.71% Shares
STATE STREET CORP $401,330 348,983 1.65% Shares
TOCQUEVILLE ASSET MANAGEMENT L.P. $368,575 320,500 1.52% Shares
UBS Group AG $251,316 218,536 1.03% Shares
AMERICAN FINANCIAL GROUP INC $235,750 205,000 0.97% Shares
NORTHERN TRUST CORP $204,932 178,202 0.84% Shares
Voss Capital, LP $201,250 175,000 0.83% Shares
Texas Capital Bank Wealth Management Services Inc $164,790 143,296 0.68% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $97,681 84,940 0.40% Shares
Corient Private Wealth LP $93,480 81,287 0.38% Shares
XTX Topco Ltd $90,242 78,471 0.37% Shares
McAdam, LLC $74,236 64,553 0.31% Shares
FCA CORP /TX $60,416 52,536 0.25% Shares
RAYMOND JAMES FINANCIAL INC $57,328 49,850 0.24% Shares
Circle Wealth Management, LLC $56,168 48,842 0.23% Shares
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management $55,200 48,000 0.23% Shares
Bangor Savings Bank $46,597 40,519 0.19% Shares
Essex Financial Services, Inc. $46,000 40,000 0.19% Shares
JONES FINANCIAL COMPANIES LLLP $45,521 40,644 0.19% Shares
GABELLI FUNDS LLC $34,500 30,000 0.14% Shares
Bryn Mawr Trust Advisors, LLC $33,408 29,050 0.14% Shares
MORGAN STANLEY $32,054 27,873 0.13% Shares
HighTower Advisors, LLC $30,475 26,500 0.13% Shares
PRIVATE MANAGEMENT GROUP INC $27,600 24,000 0.11% Shares
Vanguard Global Advisers, LLC $27,187 23,641 0.11% Shares
CWA Asset Management Group, LLC $26,450 23,000 0.11% Shares
Creative Planning $25,530 22,200 0.11% Shares
Qube Research & Technologies Ltd $25,070 21,800 0.10% Shares
GAMCO INVESTORS, INC. ET AL $23,000 20,000 0.09% Shares
Cetera Investment Advisers $22,828 19,850 0.09% Shares
Rockefeller Capital Management L.P. $22,116 19,231 0.09% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $20,087 17,467 0.08% Shares
Focus Partners Wealth $19,838 17,250 0.08% Shares
Northeast Financial Consultants Inc $19,627 63,351 0.08% Shares
MERCER GLOBAL ADVISORS INC /ADV $18,344 15,951 0.08% Shares
CITIZENS FINANCIAL GROUP INC/RI $15,731 13,679 0.06% Shares
Bank of New York Mellon Corp $15,479 13,460 0.06% Shares
BRADLEY FOSTER & SARGENT INC/CT $13,480 11,722 0.06% Shares
Vanguard Personalized Indexing Management, LLC $13,334 11,595 0.05% Shares
ELEVATION POINT WEALTH PARTNERS, LLC $11,546 10,040 0.05% Shares
Vestmark Advisory Solutions, Inc. $11,546 10,040 0.05% Shares
MML INVESTORS SERVICES, LLC $11,521 10,018 0.05% Shares
Robertson Stephens Wealth Management, LLC $11,500 10,000 0.05% Shares
Retirement Planning Group, LLC $11,500 10,000 0.05% Shares
Barry Investment Advisors, LLC $11,500 10,000 0.05% Shares
Chicago Partners Investment Group LLC $10,475 10,909 0.04% Shares
CITIGROUP INC $8,763 7,620 0.04% Shares
FIFTH THIRD BANCORP $5,750 5,000 0.02% Shares
OSAIC HOLDINGS, INC. $4,830 4,200 0.02% Shares
Versant Capital Management, Inc $3,746 3,257 0.02% Shares
Smith Anglin Financial, LLC $3,718 12,000 0.02% Shares
WELLS FARGO & COMPANY/MN $3,450 3,000 0.01% Shares
Global Retirement Partners, LLC $2,300 2,000 0.01% Shares
Ariel Capital Advisors, LLC $1,578 2,250 0.01% Shares
Rialto Wealth Management, LLC $528 459 0.00% Shares
Virtu Financial LLC $96 83,434 0.00% Shares
SBI Securities Co., Ltd. $58 50 0.00% Shares
BlackRock, Inc. $54 47 0.00% Shares
FMR LLC $1 1 0.00% Shares

Company insiders 13 insiders · 4 officers · 7 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Lisa Ricciardi CEO & President April 16, 2026 P 1,715,851 1 0 $10,092
John Brendan Doyle Chief Financial Officer May 1, 2026 F 618,942 1 0 $11,300
James Michael O'Brien Chief Financial Officer March 23, 2022 A 5,000 0 0 $0
Anthony Caggiano Chief Medical Officer April 16, 2026 P 874,906 1 0 $11,100
Peggy Wallace Director June 17, 2026 A 111,461 0 0 $0
Jack A. Khattar Director June 17, 2026 A 73,500 0 0 $0
Brett P Monia Director June 17, 2026 A 73,500 0 0 $0
Ellen B Richstone Director June 17, 2026 A 83,500 0 0 $0
Fletcher Aaron G.L. Director Sept. 19, 2025 M 56,229 0 0 $0
Mark H. Breedlove Director Oct. 13, 2021 X 404,439 0 0 $0
Golden Seeds Cognition Therapeutics LLC 10% owner Sept. 27, 2022 J 0 0 0 $0
Ogden CAP Associates, LLC 10% owner Oct. 13, 2021 X 2,210,377 0 0 $0
BIOS MEMORY SPV I, LP 10% owner Oct. 13, 2021 C 60,065 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 4 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IBRN · iShares Trust 0.09% 6,057 SH Aug. 8, 2026 Daily
IWC · iShares Trust 0.02% 275,235 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 923,898 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 2,444,295 SH Aug. 8, 2026 Daily